CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
Reminder - The CTS Reentry form, CTS-00172, will be updated on Monday July 2, 2018. It's posted ...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
Reminder - On Wednesday June 6, 2018 at 10:00AM PST, we will be hosting a webinar regarding the chan...